An infant with a rare, incurable disease has become the first to successfully receive a personalized gene therapy treatment. The treatment, which utilized CRISPR gene editing, was administered to the infant, who is reportedly thriving. The specifics of the disease and the treatment's outcome are not entirely clear, but it is confirmed that the infant received a customized CRISPR treatment for a genetic disease.